Medical Malpractice and Professional Violations in Spain: A Case Study of Medication Substitution
This article examines potential professional violations within the Spanish medical system concerning the alleged substitution of a prescribed medication, baby aspirin (100mg), with an antipsychotic drug without the patient’s knowledge or consent. This situation raises serious concerns about patient safety, informed consent, and professional accountability within the Spanish healthcare system. We will analyze this situation in light of the ethical and legal framework governing medical and pharmaceutical practice in Spain, focusing on informed consent, patient rights, and the responsibilities of healthcare professionals.
Informed Consent and Patient Rights in Spain
Spanish law firmly upholds the patient’s right to be fully informed about their medical treatment. This includes the right to receive comprehensive information about their diagnosis, proposed treatment options, potential risks and benefits of each option, and possible alternatives1. This principle of informed consent is a cornerstone of the Spanish Code of Medical Ethics and Deontology, which emphasizes the patient’s autonomy in making healthcare decisions1. Before any medical intervention, including prescribing medication, doctors are obligated to obtain the patient’s free and voluntary consent after providing this comprehensive information1. This consent must be expressly given, especially for procedures that could significantly impact the patient’s health1. The alleged substitution of a prescribed medication with an antipsychotic without the patient’s knowledge or consent is a direct violation of this fundamental right.
Regulation of Healthcare Professionals in Spain
The Spanish medical system has a robust regulatory framework governing the conduct of healthcare professionals. Doctors, for example, must meet specific requirements to practice in Spain, including demonstrating proficiency in the Spanish language and registering with the provincial medical council2. This registration process ensures that doctors meet the necessary qualifications and adhere to professional standards. Similarly, pharmacists must register with the provincial Pharmaceutical Association to practice their profession3. These regulatory bodies play a crucial role in maintaining professional standards and ensuring the quality of healthcare services in Spain.
Professional Conduct and Ethical Guidelines for Doctors in Spain
Doctors in Spain are bound by a strict code of professional conduct and ethical guidelines1. These guidelines, enshrined in the Code of Medical Ethics and Deontology, emphasize the importance of patient well-being, professional integrity, and adherence to legal requirements4. Doctors are expected to prioritize the best interests of their patients and make decisions based on sound clinical judgment5. They must also maintain patient confidentiality and ensure that their staff adheres to these principles5.
Furthermore, the Code of Medical Ethics addresses the ethical considerations of conscientious objection6. This recognizes the right of healthcare professionals to object to participating in certain practices or treatments based on their moral or religious beliefs. However, this right must be balanced with the patient’s right to access necessary healthcare services.
It is important to note that studies have shown a concerning trend of declining professionalism among medical residents in Spain7. This decline raises questions about the long-term implications for patient care and the need for interventions to reinforce ethical conduct and professional values among future generations of doctors.
Professional Conduct and Ethical Guidelines for Pharmacists in Spain
Pharmacists in Spain also operate under a code of professional conduct and ethical guidelines8. They are responsible for ensuring the safe and effective dispensing of medications, providing accurate information to patients, and collaborating with other healthcare professionals to optimize patient care9. Pharmacists are expected to prioritize patient well-being and adhere to legal requirements regarding medication labeling and patient notification3. The Code of Ethics for Pharmacists explicitly states that healthcare criteria should always take precedence over economic interests8.
However, there is a recognized tension between the community pharmacy’s traditional role as a medication supplier and the increasing need for a more patient-oriented approach10. This tension highlights the evolving role of pharmacists in providing comprehensive pharmaceutical care, including patient counseling, medication reviews, and collaboration with other healthcare providers to ensure optimal medication therapy management.
Legal Requirements for Prescription Medications in Spain
Spanish law has stringent requirements for prescription medications, encompassing authorization, labeling, and dispensing practices. All medications used in Spain must have a marketing authorization granted by the Spanish Agency of Medicines and Medical Devices (AEMPS)11. This authorization is based on rigorous scientific criteria related to the quality, safety, and efficacy of the medicine11. Any changes to a medication after authorization, including changes in formulation or substitution with another drug, must undergo the same assessment process as the original authorization11.
Drug Authorization Process in Spain
The drug authorization process in Spain involves several procedures, each with specific requirements:
| Procedure | Description |
|---|---|
| National procedure | The applicant files an application with the AEMPS, providing all the information necessary for the marketing authorization of the drug in Spain. |
| Decentralized procedure | The applicant files the application for authorization simultaneously in several EU countries. The various agencies assess the medicine in collaboration, with one agency acting as coordinating or reference agency and, at the end of the process, all the agencies issue an identical authorization valid for the relevant territory. |
| Mutual recognition procedure | This is used when a drug already holds a Community marketing authorization. The holder of this authorization may file an application for recognition thereof in other EU Member States, informing both the Member State that granted the original authorization (reference Member State) and the European Medicines Agency. The reference Member State forwards the report on the assessment of the medicine to the Member States involved, who recognize the original marketing authorization if they see fit. |
| Centralized procedure | The applicant opts for an authorization for all EU Member States at the same time. In this case, the European Medicines Agency handles the administrative process and the scientific evaluations are performed by two Member States (rapporteur and co-rapporteur), which send their reports to the other Member States. A scientific committee, which reports to the European Medicines Agency, prepares the opinions of the agency relating to any issue concerning the assessment of the medicines. Once a positive technical opinion has been issued, the European Commission grants the applicant the marketing authorization, which is valid for the whole of the EU. |
Labeling Requirements
Labeling requirements for prescription medications in Spain are also stringent13. Labels must be in Spanish and include the name and EU address of the manufacturer, distributor, and/or packer13. All labels must use metric units13. Specific information must be included for medications advertised to healthcare professionals, such as the qualitative and quantitative composition, essential clinical data, and the prescription and dispensation regime14.
Carrying Medication into Spain
Individuals carrying medication into Spain must adhere to specific legal requirements. Medications must be accompanied by a copy of the prescription or a medical report to demonstrate their legitimate use15. Certain medications, such as those used to treat ADHD, pain, or anxiety, may require special awareness and documentation due to their potential for abuse or stricter regulations in Spain16.
Cross-Border Electronic Prescription Service
Spain participates in the cross-border electronic prescription service, which allows individuals to obtain medications prescribed in their home country from pharmacies in Spain17. However, this service has limitations. Certain medications, including narcotics, psychotropics, and those with more than four active ingredients, are excluded from this service17.
Pharmaceutical Access Reform
Recent reforms in Spain aim to improve access to medications and enhance transparency in drug pricing18. These reforms include an overhaul of the reference pricing system, extending clawback payments to hospitals, and incorporating patient participation in health technology assessments (HTA)18. These changes are intended to create a more competitive market for medications, ensure the rational use of medicines, and provide greater affordability for patients.
Clinical Investigations and Medical Devices
The Spanish Agency of Medicines and Medical Devices (AEMPS) has issued new instructions regarding clinical investigations with medical devices19. These instructions aim to align clinical trials with Regulation 2017/745 on medical devices and introduce additional national requirements for sponsors19. The new guidelines include adjustments to approval requirements, procedures, deadlines, and documentation for clinical investigations involving medical devices19. These changes are crucial for ensuring the safety and efficacy of medical devices used in Spain.
Pharmacovigilance in Spain
Spain has a comprehensive pharmacovigilance system to monitor the safety of medications and identify potential adverse drug reactions (ADRs)20. The system is jointly managed by the AEMPS and 17 regional pharmacovigilance centers20. Healthcare professionals and patients are encouraged to report suspected ADRs to their local regulatory agency20. This information is then analyzed to identify potential safety signals and take necessary actions to protect public health.
The following table shows the types of ADRs reported in Spain based on a 7-year analysis:
| ADR | Number of alerts | % ADR |
|---|---|---|
| Hepatitis | 9 | 6.1 |
| Death | 7 | 4.8 |
| Congenital malformation | 6…source | 100 |
This data highlights the importance of ongoing monitoring and reporting of ADRs to ensure the safe use of medications in Spain.
Potential Professional Violations in This Situation
Based on the information provided, several potential professional violations may have occurred in this situation:
Informed Consent Violation
Substituting a prescribed medication with an antipsychotic without the patient’s knowledge or consent is a clear violation of the patient’s right to informed consent1. This substitution constitutes a significant change in treatment with potential health implications, and the patient should have been fully informed and given the opportunity to consent to or refuse the change1.
Breach of Trust
The doctor’s denial of prescribing the antipsychotic and the pharmacy’s refusal to disclose information about the change create a breach of trust between the patient and the healthcare providers5. This lack of transparency undermines the doctor-patient relationship and raises concerns about professional accountability4.
Medication Labeling and Dispensing Violations
If the medication dispensed was not accurately labeled to reflect the presence of the antipsychotic, this would constitute a violation of medication labeling requirements in Spain13. Additionally, dispensing a medication different from what was prescribed raises concerns about potential errors in the dispensing process and the pharmacy’s responsibility to ensure accurate dispensing practices9.
Potential Medical Malpractice
Administering an antipsychotic medication without a proper diagnosis or medical justification could be considered medical malpractice21. Antipsychotics have potential side effects and should only be prescribed when clinically indicated20.
Recommendations for Patients
This situation highlights the importance of patient vigilance and advocacy within the healthcare system. Patients should actively participate in their treatment decisions, ask questions, and seek clarification about any concerns or discrepancies. If professional violations are suspected, patients should consider the following steps:
- Document everything: Keep detailed records of medications received, prescriptions, and any communication with healthcare providers.
- Report the incident: File a complaint with the relevant authorities, such as the AEMPS or patient advocacy organizations.
- Seek legal advice: Consult with a lawyer specializing in medical malpractice to explore legal options.
Synthesis and Conclusion
This situation underscores the critical importance of informed consent, patient rights, and professional accountability within the Spanish medical system. The alleged substitution of a prescribed medication with an antipsychotic without the patient’s knowledge or consent raises serious concerns about potential violations of ethical and legal standards.
This situation has several potential implications:
- Patient Safety: Dispensing the wrong medication can have serious consequences for a patient’s health and well-being.
- Erosion of Trust: Breaches of trust between patients and healthcare providers can damage the doctor-patient relationship and undermine confidence in the healthcare system.
- Professional Accountability: Healthcare professionals must be held accountable for their actions to ensure patient safety and uphold the integrity of the medical profession.
To address these concerns and prevent similar situations from occurring, the following recommendations are offered:
- Strengthen Informed Consent Procedures: Healthcare providers should ensure that patients receive clear and comprehensive information about their treatment, including any changes to medication.
- Improve Communication and Transparency: Open communication between healthcare providers and patients is essential to build trust and address any concerns.
- Enhance Pharmacovigilance: Continued monitoring and reporting of adverse drug reactions are crucial to identify potential medication safety issues.
- Reinforce Professional Ethics: Medical and pharmacy schools should emphasize ethical conduct, patient-centered care, and professional accountability in their curricula.
- Patient Education and Empowerment: Patients should be encouraged to actively participate in their healthcare decisions and advocate for their rights.
By upholding these principles and implementing these recommendations, the Spanish medical system can better protect patient safety, maintain trust in the doctor-patient relationship, and ensure the highest standards of professional conduct.
Works cited
- Informed consent in dentistry and medicine in Spain: Practical considerations and legality – PMC – PubMed Central, accessed January 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9054172/
- Spain | European Junior Doctors, accessed January 24, 2025, https://www.juniordoctors.eu/medicalmobility/spain
- Pharmacy-in-Spain-GSCP.pdf – Pharmine, accessed January 24, 2025, https://www.pharmine.eu/wp-content/uploads/2014/05/Pharmacy-in-Spain-GSCP.pdf
- Telemedicine in Spain today: regulatory and ethical challenges – International Bar Association, accessed January 24, 2025, https://www.ibanet.org/telemedicine-challenges-in-Spain
- Commentary on the Code of Medical Ethics and Deontology – University of Navarra, accessed January 24, 2025, https://en.unav.edu/web/humanities-and-medical-ethics-unit/bioethics-material/comentarios-al-codigo-de-etica-y-deontologia-medica/capitulo-4
- Guidelines for conscientious objection in Spain: a proposal involving prerequisites and protocolized procedure – PubMed Central, accessed January 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11040888/
- Perception of Medical Professionalism among Medical Residents in Spain – PMC, accessed January 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8623659/
- Good Pharmacy Practice in Spanish Community Pharmacy, accessed January 24, 2025, https://www.farmaceuticos.com/wp-content/uploads/2019/09/Buenas-Practicas-Ingles.pdf
- Pharmacist profession in Spain – Consejo General de Colegios Oficiales de Farmacéuticos, accessed January 24, 2025, https://www.farmaceuticos.com/internacional/pharmacy-in-spain/pharmacist-profession-in-spain/
- Primary health care policy and vision for community pharmacy and pharmacists in Spain – PMC – PubMed Central, accessed January 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7293132/
- Product standards and requirements. pharmaceutical sector – Punto de Acceso General, accessed January 24, 2025, https://administracion.gob.es/pag_Home/en/Tu-espacio-europeo/derechos-obligaciones/empresas/productos/normas-requisitos/sector-farmaceutico.html
- The authorization process of a drug in Spain: phases and requirements – Oligofastx, accessed January 24, 2025, https://oligofastx.com/the-authorization-process-of-a-drug-in-spain-phases-and-requirements/
- Spain – Labeling/Marking Requirements – International Trade Administration, accessed January 24, 2025, https://www.trade.gov/country-commercial-guides/spain-labelingmarking-requirements
- Pharmaceutical Advertising Laws and Regulations Report 2024-2025 Spain – ICLG.com, accessed January 24, 2025, https://iclg.com/practice-areas/pharmaceutical-advertising-laws-and-regulations/spain
- Customs. Regulations in Spain. Procedures – Spain.info, accessed January 24, 2025, https://www.spain.info/en/travel-tips/customs-regulations/
- Prescription Medication & Controlled Substances – School in Spain Handbook, accessed January 24, 2025, https://schoolsabroadhandbooks.middcreate.net/spain/health-safety/prescription-medication/
- Frequently asked questions on European electronic prescription interoperability, accessed January 24, 2025, https://www.sanidad.gob.es/en/areas/saludDigital/recetaElectronicaUE/faq/faq.htm
- A closer look at Spain’s new pharmaceutical access reform – Remap Consulting, accessed January 24, 2025, https://remapconsulting.com/pma-trends/a-closer-look-at-spains-new-pharmaceutical-access-reform/
- Spain: New instructions applicable to clinical investigations with medical devices, accessed January 24, 2025, https://www.globalcompliancenews.com/2023/05/18/https-insightplus-bakermckenzie-com-bm-healthcare-life-sciences-spain-new-instructions-applicable-to-clinical-investigations-with-medical-devices-issued-by-the-aemps-spanish-medicines-and-medical-de/
- Characteristics of drug safety alerts issued by the Spanish Medicines Agency – PMC, accessed January 24, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9922741/
- Ultimate Guide to Practicing Medicine in Spain – Hippocratic Adventures, accessed January 24, 2025, https://www.hippocraticadventures.com/spain/
Gemini Advanced 1.5 Pro with Deep Research
Because of a secretly uninformed(!) changed daily baby-aspirin into a dangerous antipsychotic without me being any danger, living happily on my own, without any problems or diagnoses needed, therefore no treatment plan, or my consent!
See: Hans Smedema: Kafkaësk gevangen in absurde paradox!
Gemini AI about Pels Rijcken taking on the Hans Smedema Affair!
Ordered and paid for by:
Hans Smedema B.Sc., in forced exile surviving in beautiful El Albir, Costa Blanca, Spain